首页|冠心康调控FTO的m6A甲基化抑制炎症和凋亡抗动脉粥样硬化的研究

冠心康调控FTO的m6A甲基化抑制炎症和凋亡抗动脉粥样硬化的研究

扫码查看
目的 观察冠心康对脂多糖诱导的人脐静脉内皮细胞(HUVEC)中去甲基化酶FTO甲基化水平、炎症和凋亡的影响.方法 将体外培养的HUVEC细胞随机分为空白对照(NC)组、脂多糖(LPS)组和冠心康(GXK)组.采用CCK8法检测不同浓度LPS和冠心康对HUVEC细胞增殖活性的影响,筛选出造模和冠心康干预的最佳浓度;造模及冠心康治疗24h后,利用m6A RNA定量试剂盒(比色法)检测m6A RNA甲基化水平,实时荧光定量PCR(RT-qPCR)及蛋白质印迹法(Western blotting)法检测FTO mRNA及蛋白的表达量,ELISA法检测IL-1β、IL-6、TNF-α炎症因子变化,流式细胞术检测各种细胞凋亡水平.结果 (1)分别选择1μg/mL和6μg/mL作为脂多糖和冠心康的最佳浓度;(2)与NC组比较,LPS组m6A RNA甲基化水平升高(P<0.05),与LPS组比较,冠心康组m6A RNA甲基化水平降低(P<0.05);(3)与NC组比较,LPS组FTO mRNA及蛋白表达量降低(P<0.05),与LPS组比较,冠心康干预后FTO mRNA及蛋白表达量升高(P<0.05);(4)与NC组比较,LPS组细胞上清液中IL-1β、IL-6、TNF-α炎症因子水平升高(P<0.05),与LPS组比较,冠心康组IL-1β、IL-6、TNF-α炎症因子水平下降(P<0.05);(5)与NC组比较,LPS组细胞凋亡率增加(P<0.05),与LPS组比较,冠心康组细胞凋亡率下降(P<0.05).结论 冠心康可能通过调控去甲基化酶FTO抑制LPS诱导的炎症和凋亡抗动脉粥样硬化.
Guanxinkang inhibits inflammation and apoptosis and prevents atherosclerosis by regula-ting m6A methylation of FTO
Objective To observe the effects of Guanxinkang on lipopolysaccharide-induced inflammation and apoptosis of hu-man umbilical vein endothelial cells(HUVEC)and the methylation level of demethylase FTO.Methods The cultured HUVEC cells were randomly divided into control group(NC),lipopolysaccharide(LPS)and Guanxinkang(GXK).The effects of LPS and Guanxinkang on the proliferation activity of HUVEC cells were detected by CCK8 method,and the optimal concentration of Guanxinkang and Guanxinkang were selected.After molding and Guanxinkang treatment for24h,m6A RNA methylation level was detected by m6A RNA quantitative kit(colorimetric method),and FTO mRNA and protein expression levels were detected by real-time fluorescence quantitative PCR(RT-qPCR)and Western blotting.The changes of IL-1β,IL-6 and TNF-α inflam-matory factors were detected by ELISA,and apoptosis levels of various cells were detected by flow cytometry.Results(1)The optimal concentrations of LPS and GXK were determined to be 1 μg/mL and 6 μg/mL.(2)Compared with the NC group,the methylation level of m6A RNA increased in the LPS group(P<0.05),while it decreased in the GXK group compared to the LPS group(P<0.05).(3)The expression levels of FTO mRNA and protein decreased in the LPS group compared with the NC group(P<0.05),whereas after GXK intervention,these levels increased compared to the LPS group(P<0.05).(4)The levels of inflammatory factors IL-1β,IL-6,and TNF-α in the cell supernatant were elevated in the LPS group compared to the NC group(P<0.05),while they decreased in the GXK group compared to the LPS group(P<0.05).(5)The apoptotic rate of cells increased in the LPS group compared to the NC group(P<0.05),whereas it decreased in the GXK group compared to the LPS group(P<0.05).Conclusion Guanxinkang may inhibit LPS-induced inflammation and apoptosis by regulating demethylase FTO to prevent atherosclerosis.

GuanxinkangFTOInflammationApoptosisAtherosclerosis

吴奇东、陶丽、陈冉、丁利建、张余梁、张少恒、邱秀秀、章怡祎

展开 >

上海中医药大学附属龙华医院,上海 200032

冠心康 FTO 炎症 凋亡 动脉粥样硬化

国家自然科学基金青年基金顾仁樾上海市名老中医学术经验研究工作室建设项目龙医科技创新培育计划

81302928SHGZS-202243YD202224

2024

时珍国医国药
时珍国医国药杂志社

时珍国医国药

北大核心
影响因子:0.887
ISSN:1008-0805
年,卷(期):2024.35(6)
  • 5